CALABRETTA, Bruno
CALABRETTA, Bruno
Dipartimento Chirurgico,Medico,Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa
A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro.
1988-01-01 Gewirtz, Am; Calabretta, Bruno
A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element.
1996-01-01 Perrotti, D; Bellón, T; Trotta, R; Martinez, R; Calabretta, Bruno
A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells
2007-01-01 Corradini, Francesca; Bussolari, Rita; Cerioli, D; Lidonnici, Mr; Calabretta, Bruno
A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice.
1992-01-01 Skórski, T; Nieborowska Skórska, M; CALABRETTA, Bruno
Activation of human B-MYB by cyclins.
1997-01-01 Sala, A; Kundu, M; Casella, I; Engelhard, A; Calabretta, Bruno; Grasso, L; Paggi, Mg; Giordano, A; Watson, Rj; Khalili, K; Peschle, C.
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.
1999-01-01 Majewski, M; Nieborowska Skorska, M; Salomoni, Paolo; Slupianek, A; Reiss, K; Trotta, R; Calabretta, Bruno; Skorski, T.
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide
2008-01-01 Vitali, R; Cesi, V; Tanno, B; Ferrari, Giovanna; Dominici, C; Calabretta, Bruno; Raschellà, G.
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model
2009-01-01 Vitali, R; Mancini, C; Cesi, V; Tanno, B; Piscitelli, M; Mancuso, M; Sesti, F; Pasquali, E; Calabretta, Bruno; Dominici, C; Raschellà, G.
Altered expression of G1 specific genes in human malignant myeloid cells.
1986-01-01 Calabretta, Bruno; D., Venturelli; L., Kaczmarek; Narni, Franco; M., Talpaz; B., Anderson; M., Beran; R., Baserga
Altered expression of growth-regulated protooncogenes in human malignant plasma cells.
1989-01-01 Palumbo, Ap; Pileri, A; Dianzani, U; Massaia, M; Boccadoro, M; Calabretta, Bruno
Altered mRNA translation: possible mechanism for CML disease progression.
2003-01-01 Perrotti, D; Trotta, R; Calabretta, Bruno
An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
1989-01-01 Anfossi, G; Gewirtz, Am; Calabretta, Bruno
Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo
1997-01-01 Skorski, T; Perrotti, D; Nieborowska Skorska, M; Gryaznov, S; Calabretta, Bruno
Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
1994-01-01 Smetsers, Tf; Skorski, T; van de Locht, Lt; Wessels, Hm; Pennings, Ah; de Witte, T; Calabretta, Bruno; Mensink, E. J.
Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha.
1991-01-01 Valtieri, M; Venturelli, D; Caré, A; Fossati, C; Pelosi, E; Labbaye, C; Mattia, G; Gewirtz, Am; Calabretta, Bruno; Peschle, C.
Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice.
1996-01-01 Skorski, T; Nieborowska Skorska, M; Wlodarski, P; Zon, G; Iozzo, Rv; Calabretta, Bruno
Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise?
1995-01-01 de Fabritiis, P; Calabretta, Bruno
Antisense oligonucleotides.
1992-01-01 Calabretta, Bruno; Skorski, T; Zon, G.
Antisense strategies in the treatment of leukemias.
1996-01-01 Calabretta, Bruno; Skorski, T; Ratajczak, Mz; Gewirtz, A. M.
Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
1996-01-01 Leonetti, C; D'Agnano, I; Lozupone, F; Valentini, A; Geiser, T; Zon, G; Calabretta, Bruno; Citro G., C; Zupi, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. | 1-gen-1988 | Gewirtz, Am; Calabretta, Bruno | |
| A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element. | 1-gen-1996 | Perrotti, D; Bellón, T; Trotta, R; Martinez, R; Calabretta, Bruno | |
| A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells | 1-gen-2007 | Corradini, Francesca; Bussolari, Rita; Cerioli, D; Lidonnici, Mr; Calabretta, Bruno | |
| A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice. | 1-gen-1992 | Skórski, T; Nieborowska Skórska, M; CALABRETTA, Bruno | |
| Activation of human B-MYB by cyclins. | 1-gen-1997 | Sala, A; Kundu, M; Casella, I; Engelhard, A; Calabretta, Bruno; Grasso, L; Paggi, Mg; Giordano, A; Watson, Rj; Khalili, K; Peschle, C. | |
| Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. | 1-gen-1999 | Majewski, M; Nieborowska Skorska, M; Salomoni, Paolo; Slupianek, A; Reiss, K; Trotta, R; Calabretta, Bruno; Skorski, T. | |
| Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide | 1-gen-2008 | Vitali, R; Cesi, V; Tanno, B; Ferrari, Giovanna; Dominici, C; Calabretta, Bruno; Raschellà, G. | |
| Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model | 1-gen-2009 | Vitali, R; Mancini, C; Cesi, V; Tanno, B; Piscitelli, M; Mancuso, M; Sesti, F; Pasquali, E; Calabretta, Bruno; Dominici, C; Raschellà, G. | |
| Altered expression of G1 specific genes in human malignant myeloid cells. | 1-gen-1986 | Calabretta, Bruno; D., Venturelli; L., Kaczmarek; Narni, Franco; M., Talpaz; B., Anderson; M., Beran; R., Baserga | |
| Altered expression of growth-regulated protooncogenes in human malignant plasma cells. | 1-gen-1989 | Palumbo, Ap; Pileri, A; Dianzani, U; Massaia, M; Boccadoro, M; Calabretta, Bruno | |
| Altered mRNA translation: possible mechanism for CML disease progression. | 1-gen-2003 | Perrotti, D; Trotta, R; Calabretta, Bruno | |
| An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. | 1-gen-1989 | Anfossi, G; Gewirtz, Am; Calabretta, Bruno | |
| Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo | 1-gen-1997 | Skorski, T; Perrotti, D; Nieborowska Skorska, M; Gryaznov, S; Calabretta, Bruno | |
| Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173. | 1-gen-1994 | Smetsers, Tf; Skorski, T; van de Locht, Lt; Wessels, Hm; Pennings, Ah; de Witte, T; Calabretta, Bruno; Mensink, E. J. | |
| Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha. | 1-gen-1991 | Valtieri, M; Venturelli, D; Caré, A; Fossati, C; Pelosi, E; Labbaye, C; Mattia, G; Gewirtz, Am; Calabretta, Bruno; Peschle, C. | |
| Antisense oligodeoxynucleotide combination therapy of primary chronic myelogenous leukemia blast crisis in SCID mice. | 1-gen-1996 | Skorski, T; Nieborowska Skorska, M; Wlodarski, P; Zon, G; Iozzo, Rv; Calabretta, Bruno | |
| Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise? | 1-gen-1995 | de Fabritiis, P; Calabretta, Bruno | |
| Antisense oligonucleotides. | 1-gen-1992 | Calabretta, Bruno; Skorski, T; Zon, G. | |
| Antisense strategies in the treatment of leukemias. | 1-gen-1996 | Calabretta, Bruno; Skorski, T; Ratajczak, Mz; Gewirtz, A. M. | |
| Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice. | 1-gen-1996 | Leonetti, C; D'Agnano, I; Lozupone, F; Valentini, A; Geiser, T; Zon, G; Calabretta, Bruno; Citro G., C; Zupi, G. |